Insider Actions for ICU Medical Inc.
11/15/2022 |
Virginia Sanzone VP, General Counsel |
325 | Disposition at $160.12 per share. | 52,039 |
09/21/2022 |
George A. Lopez Director |
79,576 | Derivative/Non-derivative trans. at $61.76 per share. | 4,914,613 |
05/23/2022 |
Vivek Jain Chairman and CEO; Director |
30 | Gift at $0 per share. | 0 |
05/13/2022 |
Elisha Wade Finney Director |
743 | Gift at $0 per share. | 0 |
05/12/2022 |
George A. Lopez Director |
17 | Acquisition at $174.66 per share. | 2,969 |
05/12/2022 |
George A. Lopez Director |
9,329 | Acquisition at $174.17 per share. | 1,624,831 |
05/12/2022 |
George A. Lopez Director |
7,092 | Acquisition at $173.07 per share. | 1,227,412 |
05/12/2022 |
George A. Lopez Director |
4,917 | Acquisition at $172.24 per share. | 846,904 |
05/12/2022 |
George A. Lopez Director |
4,480 | Acquisition at $170.79 per share. | 765,139 |
05/12/2022 |
Virginia Sanzone VP, General Counsel |
750 | Disposition at $173.56 per share. | 130,170 |
05/12/2022 |
Elisha Wade Finney Director |
217 | Disposition at $170.53 per share. | 37,005 |
05/11/2022 |
David C. Greenberg Director |
433 | Derivative/Non-derivative trans. at $0 per share. | 0 |
05/11/2022 |
David F. Hoffmeister Director |
433 | Derivative/Non-derivative trans. at $0 per share. | 0 |
05/11/2022 |
Donald M. Abbey Director |
433 | Derivative/Non-derivative trans. at $0 per share. | 0 |
05/11/2022 |
Elisha Wade Finney Director |
433 | Derivative/Non-derivative trans. at $0 per share. | 0 |
05/11/2022 |
Laurie Hernandez Director |
352 | Derivative/Non-derivative trans. at $0 per share. | 0 |
05/11/2022 |
Kolleen T. Kennedy Director |
129 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/08/2022 |
Vivek Jain Chairman and CEO; Director |
1,328 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/08/2022 |
Christian B. Voigtlander Chief Operating Officer |
1,163 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/08/2022 |
Daniel Woolson VP, GM-Infusion Capital |
894 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/08/2022 |
Brian M. Bonnell Chief Financial Officer |
1,163 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/08/2022 |
Kevin J. McGrody Chief Accounting Officer |
442 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/08/2022 |
Virginia Sanzone VP, General Counsel |
1,196 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/08/2022 |
Vivek Jain Chairman and CEO; Director |
2,524 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/08/2022 |
Christian B. Voigtlander Chief Operating Officer |
2,209 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/08/2022 |
Daniel Woolson VP, GM-Infusion Capital |
2,020 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/08/2022 |
Brian M. Bonnell Chief Financial Officer |
2,209 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/08/2022 |
Kevin J. McGrody Chief Accounting Officer |
841 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/08/2022 |
Virginia Sanzone VP, General Counsel |
2,272 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/06/2022 |
Vivek Jain Chairman and CEO; Director |
760 | Derivative/Non-derivative trans. at $242.93 per share. | 184,626 |
03/06/2022 |
Vivek Jain Chairman and CEO; Director |
932 | Derivative/Non-derivative trans. at $242.93 per share. | 226,410 |
03/06/2022 |
Christian B. Voigtlander Chief Operating Officer |
816 | Derivative/Non-derivative trans. at $242.93 per share. | 198,230 |
03/06/2022 |
Christian B. Voigtlander Chief Operating Officer |
760 | Derivative/Non-derivative trans. at $242.93 per share. | 184,626 |
03/06/2022 |
Daniel Woolson VP, GM-Infusion Capital |
628 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/06/2022 |
Daniel Woolson VP, GM-Infusion Capital |
639 | Derivative/Non-derivative trans. at $242.93 per share. | 155,232 |
03/06/2022 |
Brian M. Bonnell Chief Financial Officer |
816 | Derivative/Non-derivative trans. at $242.93 per share. | 198,230 |
03/06/2022 |
Brian M. Bonnell Chief Financial Officer |
380 | Derivative/Non-derivative trans. at $242.93 per share. | 92,313 |
03/06/2022 |
Kevin J. McGrody Chief Accounting Officer |
466 | Derivative/Non-derivative trans. at $242.93 per share. | 113,205 |
03/06/2022 |
Kevin J. McGrody Chief Accounting Officer |
532 | Derivative/Non-derivative trans. at $242.93 per share. | 129,238 |
03/06/2022 |
Virginia Sanzone VP, General Counsel |
839 | Derivative/Non-derivative trans. at $242.93 per share. | 203,818 |
03/06/2022 |
Virginia Sanzone VP, General Counsel |
760 | Derivative/Non-derivative trans. at $242.93 per share. | 184,626 |
03/06/2022 |
Vivek Jain Chairman and CEO; Director |
1,444 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/06/2022 |
Vivek Jain Chairman and CEO; Director |
1,772 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/06/2022 |
Christian B. Voigtlander Chief Operating Officer |
1,551 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/06/2022 |
Christian B. Voigtlander Chief Operating Officer |
1,444 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/06/2022 |
Daniel Woolson VP, GM-Infusion Capital |
1,418 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/06/2022 |
Daniel Woolson VP, GM-Infusion Capital |
1,444 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/06/2022 |
Brian M. Bonnell Chief Financial Officer |
1,551 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/06/2022 |
Brian M. Bonnell Chief Financial Officer |
722 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/06/2022 |
Kevin J. McGrody Chief Accounting Officer |
886 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/06/2022 |
Kevin J. McGrody Chief Accounting Officer |
1,011 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/06/2022 |
Virginia Sanzone VP, General Counsel |
1,595 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/06/2022 |
Virginia Sanzone VP, General Counsel |
1,444 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/03/2022 |
Vivek Jain Chairman and CEO; Director |
36,000 | Disposition at $240 per share. | 8,640,000 |
03/03/2022 |
Vivek Jain Chairman and CEO; Director |
36,000 | Derivative/Non-derivative trans. at $58.79 per share. | 2,116,440 |
12/30/2021 |
Vivek Jain Chairman and CEO; Director |
1,159 | Disposition at $240 per share. | 278,160 |
12/30/2021 |
Vivek Jain Chairman and CEO; Director |
1,159 | Derivative/Non-derivative trans. at $58.79 per share. | 68,137 |